ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
1500 5 9 5 9 B-lower_bound
mm3 10 13 10 13 I-lower_bound
< 14 15 14 15 O
120 15 18 15 18 B-upper_bound
days 19 23 19 23 I-upper_bound
prior 24 29 24 29 I-upper_bound
to 30 32 30 32 O
registration 33 45 33 45 O

Concurrent 0 10 46 56 O
use 11 14 57 60 O
of 15 17 61 63 O
amifostine 18 28 64 74 B-treatment
, 28 29 74 75 O
concurrent 30 40 76 86 O
abdominal 41 50 87 96 B-treatment
radiotherapy 51 63 97 109 I-treatment
; 63 64 109 110 O
concurrent 65 75 111 121 O
use 76 79 122 125 O
of 80 82 126 128 O
quinolone 83 92 129 138 B-treatment
antibiotic 93 103 139 149 I-treatment
therapy 104 111 150 157 I-treatment

Have 0 4 158 162 O
chronic 5 12 163 170 O
nausea 13 19 171 177 O
that 20 24 178 182 O
has 25 28 183 186 O
been 29 33 187 191 O
present 34 41 192 199 O
for 42 45 200 203 O
at 46 48 204 206 O
least 49 54 207 212 O
one 55 58 213 216 B-lower_bound
week 59 63 217 221 O
( 64 65 222 223 O
worst 65 70 223 228 B-clinical_variable
daily 71 76 229 234 I-clinical_variable
score 77 82 235 240 I-clinical_variable
> 83 84 241 242 O
3 84 85 242 243 B-lower_bound
, 85 86 243 244 O
0 87 88 245 246 B-lower_bound
- 88 89 246 247 O
10 89 91 247 249 B-upper_bound
visual 92 98 250 256 B-clinical_variable
analogue 99 107 257 265 I-clinical_variable
scale 108 113 266 271 I-clinical_variable
) 113 114 271 272 O
or 115 117 273 275 O
vomiting 118 126 276 284 O
at 127 129 285 287 O
least 130 135 288 293 O
five 136 140 294 298 B-lower_bound
times 141 146 299 304 I-lower_bound
over 147 151 305 309 O
past 152 156 310 314 O
one 157 160 315 318 O
week 161 165 319 323 O

Have 0 4 324 328 O
histologically 5 19 329 343 O
or 20 22 344 346 O
cytologically 23 36 347 360 O
- 36 37 360 361 O
confirmed 37 46 361 370 O
malignant 47 56 371 380 B-cancer
disease 57 64 381 388 I-cancer
in 65 67 389 391 O
an 68 70 392 394 O
advanced 71 79 395 403 O
incurable 80 89 404 413 O
stage 90 95 414 419 O

Have 0 4 420 424 O
not 5 8 425 428 O
received 9 17 429 437 O
chemotherapy 18 30 438 450 B-treatment
or 31 33 451 453 O
radiation 34 43 454 463 B-treatment
for 44 47 464 467 O
> 48 49 468 469 O
14 49 51 469 471 B-lower_bound
days 52 56 472 476 I-lower_bound
( 57 58 477 478 O
advanced 58 66 478 486 O
cancer 67 73 487 493 O
patients 74 82 494 502 O
receiving 83 92 503 512 O
hormonal 93 101 513 521 B-treatment
therapy 102 109 522 529 I-treatment
or 110 112 530 532 O
targeted 113 121 533 541 B-treatment
therapy 122 129 542 549 I-treatment
that 130 134 550 554 O
does 135 139 555 559 O
not 140 143 560 563 O
come 144 148 564 568 O
with 149 153 569 573 O
a 154 155 574 575 O
recommendation 156 170 576 590 O
for 171 174 591 594 O
prophylactic 175 187 595 607 B-treatment
anti 188 192 608 612 I-treatment
- 192 193 612 613 I-treatment
emetic 193 199 613 619 I-treatment
therapy 200 207 620 627 I-treatment
are 208 211 628 631 O
eligible 212 220 632 640 O
) 220 221 640 641 O

Have 0 4 642 646 O
serum 5 10 647 652 B-clinical_variable
creatinine 11 21 653 663 I-clinical_variable
< 22 23 664 665 O
2.0 24 27 666 669 B-upper_bound
mg 28 30 670 672 I-upper_bound
/ 30 31 672 673 I-upper_bound
dl 31 33 673 675 I-upper_bound
and 34 37 676 679 O
SGOT 38 42 680 684 B-treatment
or 43 45 685 687 O
SGPT 46 50 688 692 B-treatment
< 51 52 693 694 O
3 53 54 695 696 B-upper_bound
times 55 60 697 702 I-upper_bound
upper 61 66 703 708 I-upper_bound
limits 67 73 709 715 I-upper_bound
of 74 76 716 718 I-upper_bound
normal 77 83 719 725 I-upper_bound
â‰¤120 84 88 726 730 O
days 89 93 731 735 I-upper_bound
prior 94 99 736 741 I-upper_bound
to 100 102 742 744 O
registration 103 115 745 757 O

History 0 7 758 765 O
of 8 10 766 768 O
CNS 11 14 769 772 B-chronic_disease
disease 15 22 773 780 I-chronic_disease
( 23 24 781 782 O
e.g. 24 28 782 786 O
brain 29 34 787 792 B-cancer
metastases 35 45 793 803 I-cancer
, 45 46 803 804 O
seizure 47 54 805 812 B-chronic_disease
disorder 55 63 813 821 I-chronic_disease
) 63 64 821 822 O

History 0 7 823 830 O
of 8 10 831 833 O
uncontrolled 11 23 834 846 O
diabetes 24 32 847 855 B-chronic_disease
mellitus 33 41 856 864 I-chronic_disease
( 42 43 865 866 O
stable 43 49 866 872 O
insulin 50 57 873 880 B-treatment
dose 58 62 881 885 O
and/or 63 69 886 892 O
stable 70 76 893 899 O
oral 77 81 900 904 B-treatment
hypoglycemic 82 94 905 917 I-treatment
agent 95 100 918 923 I-treatment
permitted 101 110 924 933 O
) 110 111 933 934 O

Not 0 3 935 938 O
have 4 8 939 943 O
concurrent 9 19 944 954 O
use 20 23 955 958 O
of 24 26 959 961 O
ethyol 27 33 962 968 B-treatment

Women 0 5 969 974 B-gender
of 6 8 975 977 O
childbearing 9 21 978 990 O
potential 22 31 991 1000 O
must 32 36 1001 1005 O
consent 37 44 1006 1013 B-contraception_consent
to 45 47 1014 1016 I-contraception_consent
use 48 51 1017 1020 I-contraception_consent
adequate 52 60 1021 1029 I-contraception_consent
contraception 61 74 1030 1043 I-contraception_consent
throughout 75 85 1044 1054 O
protocol 86 94 1055 1063 O
therapy 95 102 1064 1071 B-treatment

females 0 7 1072 1079 B-gender
of 8 10 1080 1082 O
childbearing 11 23 1083 1095 O
potential 24 33 1096 1105 O
must 34 38 1106 1110 O
have 39 43 1111 1115 O
a 44 45 1116 1117 O
negative 46 54 1118 1126 B-pregnancy
urine 55 60 1127 1132 I-pregnancy
pregnancy 61 70 1133 1142 I-pregnancy
test 71 75 1143 1147 O
< 76 77 1148 1149 O
7 77 78 1149 1150 B-upper_bound
days 79 83 1151 1155 I-upper_bound
prior 84 89 1156 1161 I-upper_bound
to 90 92 1162 1164 O
registration 93 105 1165 1177 O

